After raising $260M, Imperative Care looks to build portfolio of stroke-care companies

Imperative Care, a company with two FDA-cleared devices for stroke treatment, recently raised $160 million in a funding round led by D1 Capital Partners. It’s using the funds to build a portfolio of companies to treat stroke and vascular disease.